Alomone Labs

Company Overview

Snapshot

Founded in June 1989, Alomone Labs operates with 11–50 employees. The company specializes in providing ion channel, G-protein-coupled receptor (GPCR), and neural signaling tools, serving the global market with its specialized products.

Business overview

Alomone Labs develops and supplies specialized research tools for ion channel, G-protein-coupled receptor (GPCR), and neural signaling research. The company's core offerings include primary antibodies, small molecules, and proteins and peptides, all designed for use in basic science research. Alomone Labs serves the global life sciences and healthcare industries, particularly laboratories and pharmaceutical companies, by providing bioassay-validated products in lyophilized powder form to ensure biological activity and extended shelf life.

Company Intelligence Q&A

What is Alomone Labs' primary focus?

Alomone Labs focuses on supplying ion channel, G-protein-coupled receptor (GPCR), and neural signaling tools for basic science research.

What types of products does Alomone Labs offer?

Alomone Labs specializes in the production of primary antibodies, small molecules, and proteins and peptides.

What is a key characteristic of Alomone Labs' products?

All products from Alomone Labs undergo bioassay validation and are supplied in lyophilized powder form to ensure biological activity and a long shelf life.

Which markets does Alomone Labs serve?

Alomone Labs serves the global market, providing its specialized research tools to scientists worldwide.

What is the company's employee count?

Alomone Labs operates with 11–50 employees.